Watch Ticker

Caribou Biosciences, Inc. Common Stock

Go to Caribou Biosciences, Inc. Common Stock Website

$2.04

0.00 (0.00%)

Live

Previous Close

$2.04

Day Range

$0 - $0

Previous Day Range

$1.995 - $2.11

Market Cap

$195.3 million USD

Day Vol.

Previous Day Vol.

1.2 million

Currency

USD

Primary Exchange

Nasdaq

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Bragar Eagel & Squire, P.C. - CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating Caribou Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Law firm investigating potential claims against Caribou Biosciences regarding allegedly misleading statements about its cell therapy product CB-010's safety, efficacy, and financial prospects during July 2023-2024 period.

Related tickers: CRBU.

Read Full Article

N/A - Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference

Caribou Biosciences, a clinical-stage CRISPR genome-editing biopharmaceutical company, announced a strategic pipeline prioritization with a focus on its CB-010 and CB-011 oncology programs. The company expects this move to extend its cash runway by one year into H2 2027.

Related tickers: CRBU.

Read Full Article

Trending Tickers

Please sign in to view